Tumor vaccines: Unleashing the power of the immune system to fight cancer
D Liu, X Che, X Wang, C Ma, G Wu - Pharmaceuticals, 2023 - mdpi.com
This comprehensive review delves into the rapidly evolving arena of cancer vaccines.
Initially, we examine the intricate constitution of the tumor microenvironment (TME), a …
Initially, we examine the intricate constitution of the tumor microenvironment (TME), a …
Tyrosol improves ovalbumin (OVA)-induced asthma in rat model through prevention of airway inflammation
Asthma is an inflammatory disease that affects many people around the world, especially
persons at paediatric age group. The effectiveness of tyrosol, a natural phenolic compound …
persons at paediatric age group. The effectiveness of tyrosol, a natural phenolic compound …
[HTML][HTML] Immune-related adverse event profile of combination treatment of PD-(L) 1 checkpoint inhibitors and bevacizumab in non-small cell lung cancer patients: data …
S Bai, T Tian, JM Pacheco, M Tachihara… - Translational Lung …, 2021 - ncbi.nlm.nih.gov
Background Immune checkpoint inhibitors (ICIs) and bevacizumab-based therapy are a
promising treatment approach to significantly improving overall survival (OS) of non-small …
promising treatment approach to significantly improving overall survival (OS) of non-small …
Five metastasis-related mRNAs signature predicting the survival of patients with liver hepatocellular carcinoma
C Chen, YQ Liu, SX Qiu, Y Li, NJ Yu, K Liu, LM Zhong - BMC cancer, 2021 - Springer
Backgrounds Liver hepatocellular carcinoma (HCC) is one of the most malignant tumors, of
which prognosis is unsatisfactory in most cases and metastatic of HCC often results in poor …
which prognosis is unsatisfactory in most cases and metastatic of HCC often results in poor …
Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma-and Intrahepatic Cholangiocarcinoma …
A Romanzi, F Milosa, G Marcelli, RM Critelli, S Lasagni… - Biomedicines, 2023 - mdpi.com
Aggressive hepatocellular carcinoma (HCC) overexpressing Angiopoietin-2 (ANG-2)(a
protein linked with angiogenesis, proliferation, and epithelial–mesenchymal transition …
protein linked with angiogenesis, proliferation, and epithelial–mesenchymal transition …
Vandetanib as a prospective anti-inflammatory and anti-contractile agent in asthma
X Zeng, L Xue, W Li, P Zhao, W Chen… - Frontiers in …, 2024 - frontiersin.org
Background: Vandetanib is a small-molecule tyrosine kinase inhibitor. It exerts its
therapeutic effects primarily in a range of lung cancers by inhibiting the vascular endothelial …
therapeutic effects primarily in a range of lung cancers by inhibiting the vascular endothelial …
Four Metastasis-Related mRNAs Signature Predicting the Survival of Patients With Liver Hepatocellular Carcinoma
SX Qiu, Y Li, YQ Liu, K Liu, LM Zhong - 2021 - researchsquare.com
Backgrounds: Liver hepatocellular carcinoma (LIHC) is one of the most malignant tumors, of
which prognosis is unsatisfactory in most cases and metastatic of LIHC often results in poor …
which prognosis is unsatisfactory in most cases and metastatic of LIHC often results in poor …